Marian Rewers
Concepts (901)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 1 | 360 | 2023 | 3471 | 21.080 |
Why?
| Islets of Langerhans | 111 | 2023 | 745 | 11.630 |
Why?
| Autoimmunity | 122 | 2023 | 835 | 10.920 |
Why?
| Autoantibodies | 170 | 2023 | 1382 | 10.740 |
Why?
| Celiac Disease | 50 | 2023 | 270 | 7.230 |
Why?
| Genetic Predisposition to Disease | 87 | 2023 | 2382 | 3.980 |
Why?
| Coronary Artery Disease | 34 | 2018 | 721 | 3.620 |
Why?
| Diabetic Angiopathies | 28 | 2017 | 276 | 3.350 |
Why?
| Child, Preschool | 185 | 2023 | 9938 | 3.020 |
Why?
| HLA-DQ Antigens | 36 | 2020 | 179 | 2.980 |
Why?
| HLA-DR Antigens | 27 | 2021 | 225 | 2.910 |
Why?
| Calcinosis | 23 | 2015 | 304 | 2.880 |
Why?
| Insulin Resistance | 55 | 2018 | 1214 | 2.830 |
Why?
| Insulin | 73 | 2023 | 2219 | 2.710 |
Why?
| Child | 212 | 2023 | 20014 | 2.690 |
Why?
| Infant | 157 | 2023 | 8625 | 2.530 |
Why?
| Disease Progression | 76 | 2023 | 2577 | 2.430 |
Why?
| Blood Glucose | 38 | 2022 | 2008 | 2.380 |
Why?
| Risk Factors | 155 | 2023 | 9549 | 2.320 |
Why?
| Humans | 473 | 2023 | 125132 | 2.210 |
Why?
| Transglutaminases | 28 | 2023 | 145 | 2.150 |
Why?
| Genotype | 62 | 2023 | 1960 | 2.080 |
Why?
| Prospective Studies | 95 | 2023 | 6818 | 2.050 |
Why?
| Male | 318 | 2022 | 60793 | 2.050 |
Why?
| Female | 325 | 2022 | 64890 | 1.990 |
Why?
| Biomarkers | 46 | 2023 | 3736 | 1.910 |
Why?
| Diabetic Nephropathies | 19 | 2020 | 293 | 1.790 |
Why?
| Insulin Antibodies | 22 | 2023 | 104 | 1.740 |
Why?
| Adolescent | 125 | 2023 | 19411 | 1.730 |
Why?
| Polymorphism, Single Nucleotide | 34 | 2021 | 2135 | 1.700 |
Why?
| Insulin-Secreting Cells | 15 | 2023 | 334 | 1.700 |
Why?
| Diabetic Ketoacidosis | 11 | 2023 | 174 | 1.690 |
Why?
| Glutamate Decarboxylase | 34 | 2023 | 166 | 1.570 |
Why?
| Coronary Disease | 15 | 2010 | 399 | 1.560 |
Why?
| Prediabetic State | 14 | 2023 | 241 | 1.560 |
Why?
| Autoimmune Diseases | 16 | 2019 | 406 | 1.500 |
Why?
| Diet | 28 | 2021 | 1178 | 1.470 |
Why?
| Case-Control Studies | 56 | 2023 | 3326 | 1.420 |
Why?
| Hyperglycemia | 9 | 2015 | 335 | 1.410 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 10 | 2022 | 47 | 1.320 |
Why?
| Follow-Up Studies | 60 | 2021 | 4824 | 1.280 |
Why?
| Glutens | 11 | 2023 | 56 | 1.280 |
Why?
| HLA Antigens | 23 | 2021 | 235 | 1.270 |
Why?
| Cohort Studies | 66 | 2022 | 5348 | 1.230 |
Why?
| Fatty Acids, Omega-3 | 8 | 2020 | 125 | 1.220 |
Why?
| Adult | 155 | 2023 | 33168 | 1.190 |
Why?
| Diabetes Mellitus, Type 2 | 33 | 2022 | 2236 | 1.180 |
Why?
| Mass Screening | 20 | 2022 | 1119 | 1.180 |
Why?
| Enterovirus Infections | 6 | 2023 | 167 | 1.170 |
Why?
| Environment | 5 | 2018 | 355 | 1.100 |
Why?
| Polymorphism, Genetic | 15 | 2019 | 669 | 1.090 |
Why?
| Middle Aged | 135 | 2021 | 29112 | 1.060 |
Why?
| H(+)-K(+)-Exchanging ATPase | 2 | 2017 | 15 | 1.050 |
Why?
| Erythrocyte Membrane | 5 | 2015 | 52 | 1.040 |
Why?
| Atherosclerosis | 15 | 2018 | 360 | 1.010 |
Why?
| Infant, Newborn | 61 | 2023 | 5456 | 0.990 |
Why?
| Incidence | 35 | 2022 | 2578 | 0.920 |
Why?
| Colorado | 41 | 2023 | 4471 | 0.910 |
Why?
| Albuminuria | 12 | 2016 | 199 | 0.910 |
Why?
| Enterovirus | 5 | 2019 | 73 | 0.910 |
Why?
| Diabetes Complications | 7 | 2019 | 231 | 0.900 |
Why?
| Coronary Vessels | 8 | 2017 | 256 | 0.900 |
Why?
| HLA-DR3 Antigen | 16 | 2023 | 79 | 0.880 |
Why?
| Predictive Value of Tests | 25 | 2019 | 1992 | 0.830 |
Why?
| Proportional Hazards Models | 24 | 2021 | 1191 | 0.820 |
Why?
| Vascular Calcification | 9 | 2018 | 131 | 0.820 |
Why?
| Age of Onset | 17 | 2021 | 484 | 0.790 |
Why?
| Young Adult | 49 | 2023 | 11385 | 0.780 |
Why?
| Glucose Tolerance Test | 26 | 2022 | 373 | 0.770 |
Why?
| Breast Feeding | 18 | 2021 | 394 | 0.770 |
Why?
| Blood Glucose Self-Monitoring | 6 | 2022 | 551 | 0.770 |
Why?
| Genetic Testing | 8 | 2019 | 401 | 0.750 |
Why?
| Longitudinal Studies | 24 | 2021 | 2669 | 0.750 |
Why?
| Fatty Acids | 6 | 2021 | 414 | 0.730 |
Why?
| HLA-DR4 Antigen | 16 | 2022 | 76 | 0.730 |
Why?
| Antibodies, Viral | 6 | 2023 | 561 | 0.720 |
Why?
| Calcium | 8 | 2023 | 1211 | 0.710 |
Why?
| Vitamin D | 7 | 2018 | 362 | 0.670 |
Why?
| Zinc Transporter 8 | 7 | 2021 | 87 | 0.630 |
Why?
| Infant Nutritional Physiological Phenomena | 5 | 2021 | 135 | 0.630 |
Why?
| Autoantigens | 8 | 2021 | 406 | 0.620 |
Why?
| Seroconversion | 6 | 2021 | 47 | 0.620 |
Why?
| Cross-Sectional Studies | 35 | 2023 | 4854 | 0.610 |
Why?
| Prevalence | 22 | 2023 | 2488 | 0.610 |
Why?
| Haplotypes | 12 | 2019 | 496 | 0.610 |
Why?
| Infant Food | 7 | 2018 | 63 | 0.580 |
Why?
| Logistic Models | 24 | 2017 | 2040 | 0.580 |
Why?
| Metabolomics | 5 | 2021 | 551 | 0.570 |
Why?
| Adiponectin | 5 | 2016 | 233 | 0.570 |
Why?
| Fibrinogen | 5 | 2019 | 164 | 0.560 |
Why?
| Fatty Acids, Unsaturated | 2 | 2016 | 87 | 0.560 |
Why?
| Edible Grain | 4 | 2008 | 43 | 0.560 |
Why?
| Glomerular Filtration Rate | 15 | 2020 | 709 | 0.560 |
Why?
| Lipids | 5 | 2019 | 629 | 0.550 |
Why?
| GTP-Binding Proteins | 6 | 2021 | 159 | 0.550 |
Why?
| Health Care Costs | 1 | 2020 | 415 | 0.540 |
Why?
| Monitoring, Physiologic | 2 | 2009 | 290 | 0.540 |
Why?
| Uric Acid | 6 | 2018 | 353 | 0.540 |
Why?
| Germany | 11 | 2022 | 90 | 0.540 |
Why?
| Arteriosclerosis | 17 | 2004 | 91 | 0.530 |
Why?
| Inflammation | 8 | 2017 | 2612 | 0.530 |
Why?
| Adaptor Proteins, Signal Transducing | 3 | 2013 | 400 | 0.530 |
Why?
| Hypoglycemia | 5 | 2014 | 413 | 0.530 |
Why?
| Sensitivity and Specificity | 21 | 2022 | 1885 | 0.520 |
Why?
| Age Factors | 37 | 2022 | 3152 | 0.500 |
Why?
| Triglycerides | 13 | 2020 | 551 | 0.500 |
Why?
| Hypertension | 11 | 2021 | 1257 | 0.490 |
Why?
| Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 11 | 2021 | 58 | 0.490 |
Why?
| Milk | 7 | 2017 | 133 | 0.490 |
Why?
| Luminescent Measurements | 4 | 2021 | 74 | 0.490 |
Why?
| Prenatal Exposure Delayed Effects | 6 | 2021 | 484 | 0.490 |
Why?
| Body Mass Index | 22 | 2023 | 2174 | 0.490 |
Why?
| C-Peptide | 5 | 2021 | 142 | 0.480 |
Why?
| C-Reactive Protein | 5 | 2018 | 381 | 0.480 |
Why?
| Probiotics | 3 | 2022 | 52 | 0.480 |
Why?
| Helicobacter Infections | 1 | 2014 | 26 | 0.470 |
Why?
| Helicobacter pylori | 1 | 2014 | 32 | 0.470 |
Why?
| Risk | 17 | 2020 | 896 | 0.460 |
Why?
| Time Factors | 21 | 2018 | 6780 | 0.460 |
Why?
| Asymptomatic Diseases | 3 | 2023 | 84 | 0.450 |
Why?
| Fatty Acids, Monounsaturated | 2 | 2014 | 50 | 0.450 |
Why?
| Fatty Acid Desaturases | 1 | 2013 | 34 | 0.440 |
Why?
| Immunogenetics | 1 | 2013 | 6 | 0.440 |
Why?
| Alleles | 14 | 2021 | 865 | 0.440 |
Why?
| Dyslipidemias | 4 | 2015 | 169 | 0.440 |
Why?
| Prognosis | 17 | 2021 | 3616 | 0.440 |
Why?
| Finland | 14 | 2022 | 72 | 0.430 |
Why?
| Risk Assessment | 17 | 2021 | 3274 | 0.430 |
Why?
| Glucose Clamp Technique | 8 | 2020 | 198 | 0.430 |
Why?
| Dietary Supplements | 6 | 2019 | 478 | 0.420 |
Why?
| Oxylipins | 3 | 2023 | 27 | 0.420 |
Why?
| HLA-D Antigens | 5 | 2019 | 36 | 0.420 |
Why?
| Hypoglycemic Agents | 8 | 2020 | 1081 | 0.410 |
Why?
| Fasting | 12 | 2015 | 269 | 0.410 |
Why?
| Ascorbic Acid | 4 | 2023 | 116 | 0.410 |
Why?
| Child Nutritional Physiological Phenomena | 4 | 2019 | 97 | 0.410 |
Why?
| Dietary Fats | 3 | 2014 | 332 | 0.400 |
Why?
| Genome-Wide Association Study | 7 | 2021 | 1403 | 0.400 |
Why?
| Smoking | 8 | 2019 | 1635 | 0.400 |
Why?
| Antibodies | 4 | 2014 | 396 | 0.400 |
Why?
| Lipoproteins | 4 | 2015 | 175 | 0.400 |
Why?
| DNA Methylation | 3 | 2021 | 516 | 0.400 |
Why?
| Vitamin D Deficiency | 2 | 2011 | 167 | 0.400 |
Why?
| Sweden | 12 | 2021 | 65 | 0.390 |
Why?
| Apolipoproteins A | 2 | 2006 | 19 | 0.390 |
Why?
| Early Diagnosis | 6 | 2020 | 237 | 0.390 |
Why?
| Liver | 3 | 2012 | 1872 | 0.390 |
Why?
| Fetal Blood | 6 | 2021 | 278 | 0.380 |
Why?
| Sex Factors | 20 | 2020 | 1901 | 0.380 |
Why?
| Life Style | 5 | 2015 | 442 | 0.370 |
Why?
| Adipocytes | 1 | 2012 | 204 | 0.370 |
Why?
| Dietary Proteins | 4 | 2019 | 134 | 0.360 |
Why?
| Hypolipidemic Agents | 2 | 2010 | 94 | 0.360 |
Why?
| Precision Medicine | 1 | 2014 | 378 | 0.360 |
Why?
| Plant Proteins | 1 | 2011 | 83 | 0.360 |
Why?
| Epidemics | 1 | 2011 | 76 | 0.350 |
Why?
| Cholesterol, HDL | 8 | 2015 | 217 | 0.350 |
Why?
| United States | 33 | 2022 | 13613 | 0.350 |
Why?
| Patient Education as Topic | 2 | 2005 | 734 | 0.350 |
Why?
| Evidence-Based Medicine | 1 | 2014 | 745 | 0.350 |
Why?
| Eating | 5 | 2023 | 388 | 0.340 |
Why?
| Surveys and Questionnaires | 16 | 2020 | 5062 | 0.340 |
Why?
| Obesity | 12 | 2015 | 2805 | 0.340 |
Why?
| Research | 2 | 2013 | 440 | 0.340 |
Why?
| CTLA-4 Antigen | 5 | 2017 | 87 | 0.340 |
Why?
| Steroid 21-Hydroxylase | 5 | 2012 | 30 | 0.340 |
Why?
| Blood Proteins | 3 | 2017 | 253 | 0.340 |
Why?
| Cystatin C | 6 | 2014 | 72 | 0.330 |
Why?
| Clinical Trials as Topic | 3 | 2009 | 1006 | 0.330 |
Why?
| Addison Disease | 5 | 2012 | 41 | 0.330 |
Why?
| Family Health | 8 | 2017 | 209 | 0.320 |
Why?
| Antigens, CD | 2 | 2009 | 466 | 0.320 |
Why?
| Diet, Ketogenic | 1 | 2009 | 35 | 0.320 |
Why?
| HLA-DQ beta-Chains | 11 | 2019 | 62 | 0.320 |
Why?
| Multivariate Analysis | 10 | 2016 | 1561 | 0.320 |
Why?
| Diabetes Mellitus | 8 | 2009 | 988 | 0.310 |
Why?
| Rotavirus | 2 | 2016 | 27 | 0.310 |
Why?
| Reproductive History | 1 | 2008 | 13 | 0.310 |
Why?
| Sex Distribution | 5 | 2011 | 384 | 0.300 |
Why?
| Europe | 11 | 2021 | 369 | 0.300 |
Why?
| Tomography, X-Ray Computed | 12 | 2018 | 2539 | 0.300 |
Why?
| Iron | 3 | 2023 | 236 | 0.300 |
Why?
| Angiotensin II Type 2 Receptor Blockers | 1 | 2007 | 8 | 0.300 |
Why?
| Exercise | 4 | 2023 | 1779 | 0.300 |
Why?
| Cystatins | 1 | 2007 | 7 | 0.300 |
Why?
| Adiposity | 7 | 2020 | 529 | 0.290 |
Why?
| Seroepidemiologic Studies | 4 | 2023 | 154 | 0.290 |
Why?
| Respiratory Tract Infections | 4 | 2017 | 335 | 0.290 |
Why?
| Reference Values | 10 | 2012 | 818 | 0.290 |
Why?
| Proteomics | 5 | 2021 | 903 | 0.290 |
Why?
| Adipose Tissue | 4 | 2018 | 620 | 0.290 |
Why?
| Metabolome | 2 | 2020 | 307 | 0.280 |
Why?
| Overweight | 3 | 2021 | 520 | 0.280 |
Why?
| RNA, Viral | 3 | 2019 | 587 | 0.280 |
Why?
| Aged | 44 | 2021 | 20859 | 0.280 |
Why?
| Survival Analysis | 4 | 2021 | 1341 | 0.280 |
Why?
| Patient Compliance | 3 | 2023 | 571 | 0.280 |
Why?
| Feces | 6 | 2019 | 402 | 0.280 |
Why?
| Glycopeptides | 2 | 2018 | 63 | 0.280 |
Why?
| Remission Induction | 2 | 2004 | 258 | 0.270 |
Why?
| Renin-Angiotensin System | 1 | 2007 | 87 | 0.270 |
Why?
| Major Histocompatibility Complex | 4 | 2011 | 223 | 0.270 |
Why?
| Contraception | 1 | 2008 | 134 | 0.270 |
Why?
| Apolipoproteins C | 1 | 2006 | 8 | 0.270 |
Why?
| HLA-DRB1 Chains | 7 | 2019 | 100 | 0.270 |
Why?
| Rotavirus Infections | 1 | 2006 | 55 | 0.270 |
Why?
| Protein Tyrosine Phosphatases | 7 | 2006 | 149 | 0.270 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2007 | 229 | 0.260 |
Why?
| Pregnancy | 16 | 2021 | 5922 | 0.260 |
Why?
| Regression Analysis | 15 | 2014 | 1047 | 0.260 |
Why?
| Infant Formula | 3 | 2019 | 84 | 0.260 |
Why?
| Receptors, Interleukin-2 | 1 | 2005 | 67 | 0.260 |
Why?
| Immunotherapy | 1 | 2009 | 499 | 0.250 |
Why?
| Carotid Arteries | 5 | 1998 | 190 | 0.250 |
Why?
| Maternal Age | 3 | 2004 | 124 | 0.250 |
Why?
| Diet Records | 4 | 2019 | 81 | 0.250 |
Why?
| Proinsulin | 3 | 2014 | 49 | 0.250 |
Why?
| Histocompatibility Antigens Class II | 5 | 2011 | 356 | 0.250 |
Why?
| Apolipoproteins | 3 | 2014 | 40 | 0.250 |
Why?
| Glucose Intolerance | 7 | 2013 | 140 | 0.240 |
Why?
| Docosahexaenoic Acids | 3 | 2021 | 71 | 0.240 |
Why?
| Plasminogen Activator Inhibitor 1 | 6 | 2017 | 87 | 0.240 |
Why?
| Antihypertensive Agents | 2 | 2007 | 471 | 0.240 |
Why?
| Cardiovascular Diseases | 7 | 2018 | 1904 | 0.240 |
Why?
| Abdominal Wall | 1 | 2004 | 28 | 0.240 |
Why?
| Animals | 26 | 2022 | 34345 | 0.240 |
Why?
| Health Surveys | 3 | 2018 | 481 | 0.240 |
Why?
| Gene Frequency | 9 | 2020 | 528 | 0.240 |
Why?
| Tobacco Smoke Pollution | 4 | 2019 | 244 | 0.240 |
Why?
| Linear Models | 7 | 2016 | 870 | 0.240 |
Why?
| Diet, Gluten-Free | 2 | 2023 | 31 | 0.230 |
Why?
| Hyperlipidemias | 1 | 2005 | 144 | 0.230 |
Why?
| Bone Density | 2 | 2020 | 459 | 0.230 |
Why?
| Haptoglobins | 3 | 2013 | 30 | 0.230 |
Why?
| Delivery, Obstetric | 2 | 2004 | 131 | 0.230 |
Why?
| Histocompatibility Antigens Class I | 4 | 2011 | 176 | 0.230 |
Why?
| Electrochemical Techniques | 2 | 2021 | 42 | 0.230 |
Why?
| Gene-Environment Interaction | 4 | 2021 | 205 | 0.220 |
Why?
| Muscle, Skeletal | 2 | 2018 | 1568 | 0.220 |
Why?
| Birth Weight | 4 | 2016 | 477 | 0.220 |
Why?
| Child Development | 2 | 2020 | 426 | 0.220 |
Why?
| Alanine Transaminase | 2 | 2015 | 153 | 0.220 |
Why?
| Alcohol Drinking | 1 | 2009 | 710 | 0.220 |
Why?
| Iron Overload | 1 | 2023 | 10 | 0.220 |
Why?
| Genetic Variation | 3 | 2021 | 970 | 0.220 |
Why?
| Coronary Angiography | 2 | 2014 | 353 | 0.220 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 371 | 0.210 |
Why?
| ROC Curve | 4 | 2019 | 501 | 0.210 |
Why?
| Virus Diseases | 4 | 2021 | 206 | 0.210 |
Why?
| Diabetic Retinopathy | 4 | 2016 | 162 | 0.210 |
Why?
| Influenza, Human | 2 | 2022 | 569 | 0.210 |
Why?
| Ketone Bodies | 2 | 2014 | 17 | 0.210 |
Why?
| Lipid Metabolism | 2 | 2019 | 485 | 0.210 |
Why?
| Pediatrics | 4 | 2020 | 1046 | 0.210 |
Why?
| Kaplan-Meier Estimate | 4 | 2018 | 879 | 0.210 |
Why?
| Mothers | 4 | 2021 | 740 | 0.200 |
Why?
| Costs and Cost Analysis | 2 | 2020 | 213 | 0.200 |
Why?
| Parents | 6 | 2023 | 1309 | 0.200 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2010 | 420 | 0.200 |
Why?
| Micronutrients | 2 | 2017 | 82 | 0.200 |
Why?
| Maternal Nutritional Physiological Phenomena | 2 | 2021 | 158 | 0.200 |
Why?
| Gastrointestinal Microbiome | 2 | 2018 | 557 | 0.200 |
Why?
| Chromosome Mapping | 3 | 2021 | 527 | 0.200 |
Why?
| Blood Pressure | 9 | 2014 | 1735 | 0.190 |
Why?
| Lipase | 1 | 2002 | 81 | 0.190 |
Why?
| Dietary Approaches To Stop Hypertension | 1 | 2021 | 10 | 0.190 |
Why?
| Promoter Regions, Genetic | 2 | 2006 | 1195 | 0.190 |
Why?
| Gestational Age | 3 | 2020 | 797 | 0.190 |
Why?
| Body Height | 3 | 2014 | 191 | 0.190 |
Why?
| Carnitine O-Palmitoyltransferase | 1 | 2021 | 47 | 0.190 |
Why?
| Odds Ratio | 6 | 2015 | 1050 | 0.190 |
Why?
| Receptors, Calcitriol | 2 | 2012 | 58 | 0.190 |
Why?
| Monitoring, Ambulatory | 2 | 2014 | 86 | 0.190 |
Why?
| Glycerol | 2 | 2012 | 92 | 0.190 |
Why?
| Growth | 2 | 2016 | 60 | 0.190 |
Why?
| Mass Spectrometry | 3 | 2021 | 699 | 0.190 |
Why?
| White Matter | 1 | 2023 | 124 | 0.190 |
Why?
| Polysaccharides | 2 | 2022 | 88 | 0.190 |
Why?
| F2-Isoprostanes | 2 | 2015 | 17 | 0.180 |
Why?
| Gastroenteritis | 2 | 2016 | 66 | 0.180 |
Why?
| Luminescence | 3 | 2016 | 35 | 0.180 |
Why?
| Age Distribution | 4 | 2011 | 384 | 0.180 |
Why?
| Immunoglobulin A | 5 | 2021 | 176 | 0.180 |
Why?
| Vitamins | 2 | 2020 | 163 | 0.180 |
Why?
| HLA-B8 Antigen | 4 | 2012 | 14 | 0.180 |
Why?
| Genomics | 2 | 2021 | 726 | 0.180 |
Why?
| Influenza Vaccines | 2 | 2017 | 504 | 0.180 |
Why?
| Ketosis | 1 | 2020 | 13 | 0.180 |
Why?
| Reproducibility of Results | 8 | 2021 | 3047 | 0.180 |
Why?
| Neonatal Screening | 4 | 2020 | 158 | 0.180 |
Why?
| Developing Countries | 2 | 1993 | 269 | 0.170 |
Why?
| Prodromal Symptoms | 1 | 2020 | 16 | 0.170 |
Why?
| Kidney | 2 | 2018 | 1379 | 0.170 |
Why?
| Sugars | 1 | 2020 | 33 | 0.170 |
Why?
| Mannose | 1 | 2019 | 22 | 0.170 |
Why?
| Dietary Carbohydrates | 2 | 2015 | 161 | 0.170 |
Why?
| Energy Intake | 5 | 2023 | 463 | 0.170 |
Why?
| Disease Susceptibility | 6 | 2020 | 343 | 0.170 |
Why?
| Dietary Sucrose | 1 | 2020 | 55 | 0.170 |
Why?
| Biopsy | 5 | 2017 | 1093 | 0.170 |
Why?
| Life Change Events | 1 | 2021 | 143 | 0.170 |
Why?
| Mice, Inbred NOD | 5 | 2015 | 582 | 0.170 |
Why?
| Oxidative Stress | 3 | 2017 | 1210 | 0.170 |
Why?
| Pregnancy Complications, Infectious | 1 | 2003 | 301 | 0.170 |
Why?
| Quality-Adjusted Life Years | 1 | 2020 | 127 | 0.170 |
Why?
| Interferon-gamma | 2 | 2021 | 749 | 0.170 |
Why?
| Adenosine Diphosphate | 1 | 2019 | 90 | 0.170 |
Why?
| Phospholipids | 1 | 2021 | 210 | 0.170 |
Why?
| Metabolic Clearance Rate | 3 | 2014 | 115 | 0.170 |
Why?
| Epidemiologic Methods | 4 | 2014 | 74 | 0.170 |
Why?
| Peptides | 2 | 2023 | 884 | 0.170 |
Why?
| Enzyme-Linked Immunosorbent Assay | 5 | 2013 | 837 | 0.160 |
Why?
| Measles | 1 | 2019 | 40 | 0.160 |
Why?
| Cation Transport Proteins | 3 | 2011 | 125 | 0.160 |
Why?
| Butyrates | 1 | 2019 | 55 | 0.160 |
Why?
| Apolipoproteins B | 2 | 2015 | 52 | 0.160 |
Why?
| Glycosuria | 2 | 2009 | 8 | 0.160 |
Why?
| Osteoporotic Fractures | 1 | 2020 | 61 | 0.160 |
Why?
| Fatty Acids, Omega-6 | 4 | 2020 | 47 | 0.160 |
Why?
| Antibodies, Bacterial | 1 | 2019 | 130 | 0.160 |
Why?
| Cholesterol | 5 | 2014 | 390 | 0.160 |
Why?
| Uromodulin | 1 | 2018 | 28 | 0.160 |
Why?
| Cotinine | 1 | 2019 | 80 | 0.160 |
Why?
| Genetic Markers | 4 | 2013 | 368 | 0.160 |
Why?
| Self Report | 3 | 2020 | 750 | 0.160 |
Why?
| Mexican Americans | 3 | 2014 | 102 | 0.160 |
Why?
| HLA-DP beta-Chains | 3 | 2015 | 79 | 0.150 |
Why?
| Models, Biological | 5 | 2019 | 1753 | 0.150 |
Why?
| Cost-Benefit Analysis | 2 | 2020 | 578 | 0.150 |
Why?
| Health Expenditures | 1 | 2020 | 203 | 0.150 |
Why?
| High-Throughput Screening Assays | 1 | 2019 | 126 | 0.150 |
Why?
| Squalene | 1 | 2017 | 5 | 0.150 |
Why?
| HLA-DR2 Antigen | 2 | 2012 | 8 | 0.150 |
Why?
| Sodium Bicarbonate | 1 | 2018 | 51 | 0.150 |
Why?
| Polyendocrinopathies, Autoimmune | 1 | 2017 | 18 | 0.150 |
Why?
| Hypersensitivity | 1 | 2021 | 265 | 0.150 |
Why?
| Feeding Behavior | 3 | 2013 | 618 | 0.150 |
Why?
| Cost of Illness | 1 | 2020 | 289 | 0.150 |
Why?
| Genes, MHC Class II | 2 | 2012 | 73 | 0.150 |
Why?
| Immune Tolerance | 1 | 2019 | 338 | 0.150 |
Why?
| Gene Expression Profiling | 5 | 2017 | 1642 | 0.150 |
Why?
| Immunologic Memory | 1 | 2019 | 322 | 0.150 |
Why?
| Antipyretics | 1 | 2017 | 7 | 0.150 |
Why?
| Environmental Exposure | 2 | 2015 | 424 | 0.140 |
Why?
| CD4-Positive T-Lymphocytes | 3 | 2021 | 997 | 0.140 |
Why?
| Radioimmunoassay | 6 | 2016 | 170 | 0.140 |
Why?
| Blood Cell Count | 1 | 2017 | 57 | 0.140 |
Why?
| Body Composition | 3 | 2020 | 679 | 0.140 |
Why?
| Rheumatoid Factor | 3 | 2007 | 156 | 0.140 |
Why?
| Immunization | 1 | 1999 | 420 | 0.140 |
Why?
| Models, Genetic | 2 | 2017 | 607 | 0.140 |
Why?
| Osteoporosis | 1 | 2020 | 243 | 0.140 |
Why?
| Cytokines | 4 | 2017 | 1927 | 0.140 |
Why?
| Genetic Loci | 3 | 2015 | 299 | 0.140 |
Why?
| Poland | 4 | 2010 | 29 | 0.140 |
Why?
| Kidney Diseases | 2 | 2012 | 449 | 0.140 |
Why?
| Immunoglobulin G | 4 | 2021 | 808 | 0.140 |
Why?
| Epitopes | 4 | 2021 | 450 | 0.140 |
Why?
| Prenatal Nutritional Physiological Phenomena | 1 | 2017 | 67 | 0.140 |
Why?
| Proteins | 2 | 2021 | 951 | 0.140 |
Why?
| Milk Proteins | 1 | 1996 | 40 | 0.140 |
Why?
| Homozygote | 5 | 2014 | 195 | 0.140 |
Why?
| Toxins, Biological | 1 | 2016 | 16 | 0.140 |
Why?
| Arachidonic Acid | 2 | 2021 | 120 | 0.130 |
Why?
| Vitamin B 12 | 1 | 2017 | 116 | 0.130 |
Why?
| Body Weight | 3 | 2016 | 960 | 0.130 |
Why?
| Hygiene | 1 | 2016 | 35 | 0.130 |
Why?
| Cesarean Section | 1 | 2018 | 184 | 0.130 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 7 | 2006 | 45 | 0.130 |
Why?
| HLA-A1 Antigen | 2 | 2006 | 3 | 0.130 |
Why?
| HLA-DP Antigens | 2 | 2007 | 33 | 0.130 |
Why?
| Polymerase Chain Reaction | 5 | 2011 | 1042 | 0.130 |
Why?
| Models, Theoretical | 2 | 2017 | 585 | 0.130 |
Why?
| Diet Surveys | 4 | 2021 | 87 | 0.130 |
Why?
| Anorexia Nervosa | 1 | 2017 | 94 | 0.130 |
Why?
| Erythrocytes | 1 | 2021 | 642 | 0.130 |
Why?
| Practice Guidelines as Topic | 1 | 2023 | 1530 | 0.130 |
Why?
| High-Throughput Nucleotide Sequencing | 2 | 2022 | 468 | 0.130 |
Why?
| Lentigo | 1 | 2015 | 7 | 0.130 |
Why?
| Stress, Psychological | 2 | 2021 | 1044 | 0.130 |
Why?
| Oxygen | 1 | 2020 | 912 | 0.130 |
Why?
| Feeding Methods | 1 | 2015 | 6 | 0.130 |
Why?
| Rural Health | 1 | 1996 | 78 | 0.130 |
Why?
| Analgesics, Non-Narcotic | 1 | 2017 | 127 | 0.130 |
Why?
| Absorptiometry, Photon | 2 | 2020 | 238 | 0.130 |
Why?
| Histocompatibility Testing | 6 | 2017 | 125 | 0.130 |
Why?
| Renal Insufficiency, Chronic | 3 | 2018 | 612 | 0.130 |
Why?
| Oligonucleotide Array Sequence Analysis | 4 | 2011 | 785 | 0.120 |
Why?
| Complement C3 | 1 | 2016 | 193 | 0.120 |
Why?
| Carbohydrates | 1 | 2015 | 63 | 0.120 |
Why?
| Dietary Fiber | 1 | 2015 | 46 | 0.120 |
Why?
| Child Day Care Centers | 1 | 2015 | 34 | 0.120 |
Why?
| Medical Records | 2 | 2007 | 186 | 0.120 |
Why?
| Genetic Association Studies | 4 | 2020 | 391 | 0.120 |
Why?
| Periodontal Diseases | 1 | 2015 | 87 | 0.120 |
Why?
| International Agencies | 1 | 2014 | 30 | 0.120 |
Why?
| Gram-Positive Bacteria | 1 | 2014 | 47 | 0.120 |
Why?
| Fructosamine | 1 | 2014 | 21 | 0.120 |
Why?
| Dairy Products | 1 | 2014 | 31 | 0.120 |
Why?
| Health Records, Personal | 1 | 2014 | 24 | 0.120 |
Why?
| Gram-Negative Bacteria | 1 | 2014 | 72 | 0.120 |
Why?
| Up-Regulation | 2 | 2016 | 895 | 0.120 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 304 | 0.120 |
Why?
| Societies, Scientific | 1 | 2014 | 49 | 0.120 |
Why?
| Carotid Artery Diseases | 3 | 2000 | 61 | 0.120 |
Why?
| Adolescent Medicine | 1 | 2014 | 35 | 0.120 |
Why?
| Renal Insufficiency | 1 | 2016 | 155 | 0.120 |
Why?
| Genetic Linkage | 2 | 2015 | 330 | 0.120 |
Why?
| Phenotype | 7 | 2021 | 3153 | 0.120 |
Why?
| Acetaminophen | 1 | 2017 | 262 | 0.110 |
Why?
| Molecular Sequence Data | 7 | 2015 | 2926 | 0.110 |
Why?
| Bias | 1 | 2015 | 216 | 0.110 |
Why?
| Hypoxia | 1 | 2020 | 1021 | 0.110 |
Why?
| Mice | 11 | 2022 | 15984 | 0.110 |
Why?
| Eicosapentaenoic Acid | 1 | 2013 | 29 | 0.110 |
Why?
| Hemodynamics | 1 | 2018 | 1093 | 0.110 |
Why?
| Cholesterol, Dietary | 1 | 2013 | 16 | 0.110 |
Why?
| Patient Care Planning | 1 | 2014 | 151 | 0.110 |
Why?
| Eggs | 1 | 2013 | 30 | 0.110 |
Why?
| Creatinine | 4 | 2018 | 507 | 0.110 |
Why?
| Phosphates | 1 | 2014 | 170 | 0.110 |
Why?
| Tumor Suppressor Proteins | 1 | 2015 | 301 | 0.110 |
Why?
| Communicable Diseases | 1 | 2015 | 140 | 0.110 |
Why?
| Proteome | 1 | 2016 | 359 | 0.110 |
Why?
| Sex Characteristics | 7 | 2015 | 699 | 0.110 |
Why?
| Heart Rate | 3 | 2010 | 758 | 0.110 |
Why?
| Gene Expression | 3 | 2021 | 1528 | 0.110 |
Why?
| Siblings | 3 | 2018 | 252 | 0.110 |
Why?
| Pilot Projects | 4 | 2023 | 1530 | 0.110 |
Why?
| Receptors, Antigen, T-Cell | 3 | 2023 | 638 | 0.110 |
Why?
| Amino Acid Sequence | 5 | 2015 | 2098 | 0.110 |
Why?
| Immunity, Innate | 2 | 2022 | 759 | 0.100 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2012 | 11 | 0.100 |
Why?
| Biological Specimen Banks | 1 | 2013 | 105 | 0.100 |
Why?
| Monoamine Oxidase | 1 | 2012 | 53 | 0.100 |
Why?
| History, 21st Century | 1 | 2013 | 181 | 0.100 |
Why?
| Iodide Peroxidase | 4 | 2020 | 27 | 0.100 |
Why?
| Specimen Handling | 1 | 2013 | 171 | 0.100 |
Why?
| Chromosomes, Human, Pair 2 | 2 | 2009 | 27 | 0.100 |
Why?
| Research Support as Topic | 1 | 2013 | 123 | 0.100 |
Why?
| Stomach | 1 | 2012 | 106 | 0.100 |
Why?
| Lymphocytes | 1 | 2014 | 356 | 0.100 |
Why?
| Organizational Innovation | 1 | 2013 | 144 | 0.100 |
Why?
| Epistasis, Genetic | 1 | 2012 | 73 | 0.100 |
Why?
| History, 20th Century | 1 | 2013 | 290 | 0.100 |
Why?
| Viruses | 1 | 2013 | 97 | 0.100 |
Why?
| Intestine, Small | 2 | 2005 | 135 | 0.100 |
Why?
| Interleukin-4 | 2 | 2005 | 211 | 0.100 |
Why?
| Nuclear Family | 2 | 2009 | 54 | 0.100 |
Why?
| Hyperinsulinism | 2 | 2010 | 108 | 0.100 |
Why?
| Histocompatibility Antigens | 2 | 2013 | 102 | 0.100 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2016 | 836 | 0.100 |
Why?
| Intestines | 1 | 2014 | 337 | 0.100 |
Why?
| Calcifediol | 1 | 2011 | 30 | 0.100 |
Why?
| Pedigree | 4 | 2017 | 506 | 0.100 |
Why?
| Patient Selection | 3 | 2011 | 725 | 0.100 |
Why?
| Toll-Like Receptors | 1 | 2012 | 170 | 0.100 |
Why?
| Gliadin | 2 | 2009 | 12 | 0.100 |
Why?
| Combined Modality Therapy | 1 | 2014 | 1200 | 0.100 |
Why?
| Vaccines | 1 | 2016 | 380 | 0.090 |
Why?
| HLA-B Antigens | 1 | 2011 | 56 | 0.090 |
Why?
| Interleukin-2 | 1 | 2012 | 424 | 0.090 |
Why?
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2011 | 26 | 0.090 |
Why?
| Primary Prevention | 1 | 2013 | 214 | 0.090 |
Why?
| Weight Gain | 2 | 2011 | 517 | 0.090 |
Why?
| Vitamin D-Binding Protein | 1 | 2010 | 15 | 0.090 |
Why?
| Kidney Function Tests | 1 | 2011 | 164 | 0.090 |
Why?
| Milk, Human | 3 | 2018 | 146 | 0.090 |
Why?
| Video Recording | 1 | 2011 | 169 | 0.090 |
Why?
| Dose-Response Relationship, Drug | 3 | 2017 | 2026 | 0.090 |
Why?
| Decision Support Techniques | 2 | 2013 | 395 | 0.090 |
Why?
| Endocrine Cells | 1 | 2010 | 6 | 0.090 |
Why?
| Food, Fortified | 1 | 2010 | 37 | 0.090 |
Why?
| Gastrointestinal Diseases | 1 | 2012 | 194 | 0.090 |
Why?
| Vascular Diseases | 2 | 2013 | 251 | 0.090 |
Why?
| Linkage Disequilibrium | 4 | 2015 | 288 | 0.090 |
Why?
| Microbiota | 2 | 2014 | 683 | 0.090 |
Why?
| Family | 5 | 2018 | 640 | 0.090 |
Why?
| Lymphocyte Activation | 1 | 2014 | 1077 | 0.090 |
Why?
| Abdomen | 1 | 2010 | 119 | 0.090 |
Why?
| Nutrition Assessment | 2 | 2015 | 81 | 0.090 |
Why?
| Socioeconomic Factors | 5 | 2017 | 1183 | 0.090 |
Why?
| Interleukin-1beta | 1 | 2012 | 382 | 0.090 |
Why?
| Membrane Proteins | 3 | 2002 | 1089 | 0.090 |
Why?
| Myocardial Infarction | 2 | 1994 | 1142 | 0.090 |
Why?
| Leukocytes, Mononuclear | 2 | 2012 | 517 | 0.090 |
Why?
| RNA | 1 | 2016 | 875 | 0.090 |
Why?
| Monitoring, Immunologic | 1 | 2009 | 22 | 0.090 |
Why?
| Fatty Acids, Nonesterified | 1 | 2010 | 174 | 0.090 |
Why?
| Transcription Factors | 1 | 2017 | 1604 | 0.080 |
Why?
| Pancreas | 2 | 2023 | 287 | 0.080 |
Why?
| Waist-Hip Ratio | 2 | 2009 | 32 | 0.080 |
Why?
| Quality Control | 3 | 2013 | 165 | 0.080 |
Why?
| Homeostasis | 2 | 2010 | 605 | 0.080 |
Why?
| Sequence Analysis, DNA | 3 | 2011 | 767 | 0.080 |
Why?
| Bifidobacterium | 2 | 2018 | 22 | 0.080 |
Why?
| Telomere | 3 | 2022 | 215 | 0.080 |
Why?
| Antigens, Viral | 2 | 2021 | 182 | 0.080 |
Why?
| Metabolic Syndrome | 1 | 2013 | 399 | 0.080 |
Why?
| Spleen | 1 | 2010 | 513 | 0.080 |
Why?
| Magnetic Resonance Spectroscopy | 3 | 2016 | 532 | 0.080 |
Why?
| Proteinuria | 1 | 2009 | 100 | 0.080 |
Why?
| Insulin Infusion Systems | 2 | 2017 | 316 | 0.080 |
Why?
| Glycemic Index | 1 | 2008 | 24 | 0.080 |
Why?
| Environmental Monitoring | 1 | 2010 | 308 | 0.080 |
Why?
| Interleukin-6 | 1 | 2012 | 710 | 0.080 |
Why?
| Isoenzymes | 2 | 2006 | 311 | 0.080 |
Why?
| DEAD-box RNA Helicases | 1 | 2008 | 59 | 0.080 |
Why?
| Anti-Bacterial Agents | 1 | 2017 | 1559 | 0.080 |
Why?
| Disease Outbreaks | 2 | 1991 | 334 | 0.080 |
Why?
| Laboratories | 1 | 2009 | 104 | 0.070 |
Why?
| Tandem Mass Spectrometry | 2 | 2021 | 431 | 0.070 |
Why?
| Angiotensins | 1 | 2007 | 13 | 0.070 |
Why?
| Receptor, Angiotensin, Type 1 | 1 | 2007 | 23 | 0.070 |
Why?
| Antibody Formation | 1 | 2008 | 282 | 0.070 |
Why?
| Contraceptive Agents, Female | 1 | 2008 | 67 | 0.070 |
Why?
| Antidepressive Agents | 1 | 2009 | 202 | 0.070 |
Why?
| Pediatric Obesity | 1 | 2014 | 540 | 0.070 |
Why?
| Lipoproteins, LDL | 2 | 2008 | 156 | 0.070 |
Why?
| Peptidyl-Dipeptidase A | 1 | 2007 | 59 | 0.070 |
Why?
| Clinical Laboratory Techniques | 1 | 2007 | 95 | 0.070 |
Why?
| Population Surveillance | 3 | 2020 | 444 | 0.070 |
Why?
| Wheat Hypersensitivity | 1 | 2006 | 4 | 0.070 |
Why?
| Epigenesis, Genetic | 2 | 2021 | 557 | 0.070 |
Why?
| Datasets as Topic | 2 | 2018 | 106 | 0.070 |
Why?
| Contraceptives, Oral, Hormonal | 1 | 2006 | 23 | 0.070 |
Why?
| Drug Utilization | 2 | 2017 | 181 | 0.070 |
Why?
| Antibody Specificity | 4 | 2011 | 191 | 0.070 |
Why?
| Apolipoprotein C-III | 1 | 2006 | 16 | 0.070 |
Why?
| Hydrogen-Ion Concentration | 2 | 2018 | 562 | 0.070 |
Why?
| Metagenomics | 2 | 2019 | 135 | 0.070 |
Why?
| Birth Order | 2 | 2004 | 13 | 0.070 |
Why?
| Carrier State | 1 | 2006 | 57 | 0.070 |
Why?
| Adenovirus Infections, Human | 1 | 2005 | 15 | 0.070 |
Why?
| Paired Box Transcription Factors | 1 | 2005 | 40 | 0.070 |
Why?
| Neoplasm Proteins | 2 | 2020 | 409 | 0.070 |
Why?
| Adenoviruses, Human | 1 | 2005 | 26 | 0.070 |
Why?
| Receptors, Interleukin-4 | 1 | 2005 | 15 | 0.060 |
Why?
| Chronic Disease | 4 | 2017 | 1684 | 0.060 |
Why?
| Chromatography, Liquid | 3 | 2012 | 363 | 0.060 |
Why?
| Codon, Terminator | 1 | 2005 | 21 | 0.060 |
Why?
| Statistics, Nonparametric | 2 | 2011 | 429 | 0.060 |
Why?
| Antigens, Differentiation | 1 | 2005 | 79 | 0.060 |
Why?
| Amino Acid Substitution | 1 | 2006 | 279 | 0.060 |
Why?
| Capsid Proteins | 1 | 2005 | 70 | 0.060 |
Why?
| Disease Models, Animal | 2 | 2018 | 3823 | 0.060 |
Why?
| Codon, Nonsense | 1 | 2005 | 38 | 0.060 |
Why?
| Protective Factors | 2 | 2015 | 95 | 0.060 |
Why?
| Transcriptome | 2 | 2023 | 801 | 0.060 |
Why?
| Interleukin-13 | 1 | 2005 | 134 | 0.060 |
Why?
| Fathers | 1 | 2005 | 49 | 0.060 |
Why?
| Radiography, Abdominal | 1 | 2004 | 35 | 0.060 |
Why?
| Arthritis, Juvenile | 1 | 2005 | 42 | 0.060 |
Why?
| T-Lymphocytes | 2 | 2023 | 1793 | 0.060 |
Why?
| Survivors | 1 | 2008 | 460 | 0.060 |
Why?
| Nutritional Status | 1 | 2007 | 304 | 0.060 |
Why?
| Research Design | 3 | 2019 | 1035 | 0.060 |
Why?
| RNA, Ribosomal, 16S | 2 | 2018 | 524 | 0.060 |
Why?
| Norway | 2 | 2019 | 37 | 0.060 |
Why?
| Registries | 7 | 2019 | 2050 | 0.060 |
Why?
| Postmenopause | 3 | 2020 | 310 | 0.060 |
Why?
| Pennsylvania | 2 | 2018 | 107 | 0.060 |
Why?
| Anthropometry | 1 | 2004 | 205 | 0.060 |
Why?
| Waist Circumference | 2 | 2015 | 130 | 0.060 |
Why?
| Cattle | 3 | 2017 | 1010 | 0.060 |
Why?
| Insulin, Isophane | 1 | 2003 | 17 | 0.060 |
Why?
| DNA | 2 | 2011 | 1406 | 0.060 |
Why?
| Cross-Cultural Comparison | 2 | 2015 | 85 | 0.060 |
Why?
| Confidence Intervals | 1 | 2004 | 341 | 0.060 |
Why?
| International Cooperation | 3 | 2016 | 187 | 0.050 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2022 | 311 | 0.050 |
Why?
| Biomedical Research | 1 | 2009 | 641 | 0.050 |
Why?
| Iron, Dietary | 1 | 2023 | 19 | 0.050 |
Why?
| Creatine | 1 | 2023 | 56 | 0.050 |
Why?
| Aspartic Acid | 1 | 2023 | 89 | 0.050 |
Why?
| Mice, Knockout | 1 | 2009 | 2736 | 0.050 |
Why?
| Peptides, Cyclic | 1 | 2005 | 265 | 0.050 |
Why?
| Glycomics | 1 | 2022 | 9 | 0.050 |
Why?
| Markov Chains | 2 | 2020 | 122 | 0.050 |
Why?
| Renal Dialysis | 1 | 2006 | 393 | 0.050 |
Why?
| Observational Studies as Topic | 1 | 2023 | 97 | 0.050 |
Why?
| HLA-DQ alpha-Chains | 2 | 2019 | 17 | 0.050 |
Why?
| Choline | 1 | 2023 | 114 | 0.050 |
Why?
| Candida | 1 | 2022 | 37 | 0.050 |
Why?
| Multicenter Studies as Topic | 1 | 2023 | 269 | 0.050 |
Why?
| Homeodomain Proteins | 1 | 2005 | 476 | 0.050 |
Why?
| HLA-B15 Antigen | 2 | 2012 | 13 | 0.050 |
Why?
| Electrocardiography | 2 | 2010 | 637 | 0.050 |
Why?
| Insulins | 1 | 2022 | 35 | 0.050 |
Why?
| Electrochemistry | 1 | 2021 | 72 | 0.050 |
Why?
| Prenatal Care | 1 | 2004 | 277 | 0.050 |
Why?
| Epitopes, B-Lymphocyte | 1 | 2021 | 16 | 0.050 |
Why?
| CpG Islands | 1 | 2021 | 125 | 0.050 |
Why?
| Fungi | 1 | 2022 | 124 | 0.050 |
Why?
| Diagnostic Techniques, Radioisotope | 1 | 2021 | 9 | 0.050 |
Why?
| Linoleic Acid | 1 | 2021 | 41 | 0.050 |
Why?
| Perception | 1 | 2023 | 328 | 0.050 |
Why?
| China | 1 | 2021 | 225 | 0.050 |
Why?
| Immunoglobulin D | 1 | 2021 | 28 | 0.050 |
Why?
| Pregnancy Trimester, Third | 1 | 2021 | 82 | 0.050 |
Why?
| Serologic Tests | 1 | 2021 | 56 | 0.050 |
Why?
| p-Aminohippuric Acid | 1 | 2020 | 8 | 0.050 |
Why?
| Protein Interaction Mapping | 1 | 2021 | 107 | 0.050 |
Why?
| Furosemide | 1 | 2020 | 36 | 0.050 |
Why?
| Iohexol | 1 | 2020 | 20 | 0.050 |
Why?
| Benchmarking | 1 | 2022 | 189 | 0.040 |
Why?
| Isotopes | 1 | 2020 | 26 | 0.040 |
Why?
| Viral Proteins | 2 | 2006 | 302 | 0.040 |
Why?
| Dehydroascorbic Acid | 1 | 2020 | 1 | 0.040 |
Why?
| Depression | 1 | 2009 | 1236 | 0.040 |
Why?
| Drug Administration Schedule | 2 | 2017 | 760 | 0.040 |
Why?
| Models, Statistical | 3 | 2015 | 664 | 0.040 |
Why?
| Kidney Transplantation | 1 | 2006 | 593 | 0.040 |
Why?
| Drug Discovery | 1 | 2021 | 129 | 0.040 |
Why?
| Whole Genome Sequencing | 1 | 2020 | 117 | 0.040 |
Why?
| Amino Acids, Branched-Chain | 1 | 2020 | 32 | 0.040 |
Why?
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 99 | 0.040 |
Why?
| Gastrointestinal Tract | 1 | 2022 | 175 | 0.040 |
Why?
| Growth Charts | 1 | 2020 | 15 | 0.040 |
Why?
| Glucose Transporter Type 2 | 1 | 2019 | 11 | 0.040 |
Why?
| Antibody Diversity | 1 | 2019 | 17 | 0.040 |
Why?
| Antibodies, Heterophile | 1 | 1999 | 13 | 0.040 |
Why?
| Peroxidase | 1 | 2020 | 184 | 0.040 |
Why?
| Haemophilus influenzae type b | 1 | 1999 | 10 | 0.040 |
Why?
| Phosphatidylethanolamines | 1 | 2020 | 66 | 0.040 |
Why?
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 1999 | 26 | 0.040 |
Why?
| Alanine | 1 | 2020 | 104 | 0.040 |
Why?
| Poliovirus Vaccine, Inactivated | 1 | 1999 | 22 | 0.040 |
Why?
| Salaries and Fringe Benefits | 1 | 2020 | 55 | 0.040 |
Why?
| Measles-Mumps-Rubella Vaccine | 1 | 2019 | 41 | 0.040 |
Why?
| Haemophilus Vaccines | 1 | 1999 | 27 | 0.040 |
Why?
| Algorithms | 2 | 2018 | 1618 | 0.040 |
Why?
| Proline | 1 | 2020 | 71 | 0.040 |
Why?
| Femur Neck | 1 | 2020 | 66 | 0.040 |
Why?
| Immunoglobulin M | 1 | 2021 | 253 | 0.040 |
Why?
| Texas | 2 | 2014 | 202 | 0.040 |
Why?
| Hepatitis B Vaccines | 1 | 1999 | 48 | 0.040 |
Why?
| Chromatography, Reverse-Phase | 1 | 2019 | 26 | 0.040 |
Why?
| Efficiency | 1 | 2020 | 93 | 0.040 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2021 | 502 | 0.040 |
Why?
| Methionine | 1 | 2020 | 148 | 0.040 |
Why?
| Macaca mulatta | 1 | 2019 | 149 | 0.040 |
Why?
| Gene Regulatory Networks | 1 | 2021 | 243 | 0.040 |
Why?
| Bayes Theorem | 1 | 2021 | 364 | 0.040 |
Why?
| Maternal Behavior | 1 | 1999 | 69 | 0.040 |
Why?
| Pediatricians | 1 | 2020 | 125 | 0.040 |
Why?
| Gas Chromatography-Mass Spectrometry | 1 | 2019 | 144 | 0.040 |
Why?
| Immunoglobulin E | 1 | 2021 | 366 | 0.040 |
Why?
| Alternative Splicing | 1 | 2000 | 198 | 0.040 |
Why?
| Adenoviridae | 1 | 2019 | 196 | 0.040 |
Why?
| Receptor, Insulin | 1 | 1999 | 101 | 0.040 |
Why?
| Proteobacteria | 1 | 2018 | 17 | 0.040 |
Why?
| gamma-Aminobutyric Acid | 1 | 2020 | 163 | 0.040 |
Why?
| beta 2-Microglobulin | 1 | 2018 | 47 | 0.040 |
Why?
| Phosphoproteins | 1 | 2021 | 320 | 0.040 |
Why?
| Firmicutes | 1 | 2018 | 20 | 0.040 |
Why?
| Lipocalin-2 | 1 | 2018 | 66 | 0.040 |
Why?
| Pets | 1 | 2018 | 22 | 0.040 |
Why?
| Fatty Acids, Volatile | 1 | 2018 | 48 | 0.040 |
Why?
| Feasibility Studies | 2 | 2015 | 806 | 0.040 |
Why?
| Employment | 1 | 2020 | 149 | 0.040 |
Why?
| Postpartum Period | 1 | 2021 | 289 | 0.040 |
Why?
| Emotional Adjustment | 1 | 2018 | 19 | 0.040 |
Why?
| Molecular Targeted Therapy | 1 | 2021 | 361 | 0.040 |
Why?
| Down-Regulation | 1 | 2021 | 652 | 0.040 |
Why?
| Microscopy, Polarization | 1 | 2018 | 33 | 0.040 |
Why?
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2018 | 38 | 0.040 |
Why?
| Lumbar Vertebrae | 1 | 2020 | 218 | 0.040 |
Why?
| Interleukins | 1 | 2020 | 243 | 0.040 |
Why?
| Apolipoprotein A-I | 1 | 1997 | 28 | 0.040 |
Why?
| Severity of Illness Index | 2 | 2016 | 2848 | 0.040 |
Why?
| Estrogen Replacement Therapy | 1 | 1998 | 118 | 0.040 |
Why?
| Loss of Function Mutation | 1 | 2017 | 44 | 0.040 |
Why?
| Osmolar Concentration | 1 | 2018 | 196 | 0.040 |
Why?
| Quantitative Trait Loci | 1 | 2020 | 349 | 0.040 |
Why?
| Collagen | 1 | 2020 | 443 | 0.040 |
Why?
| Discriminant Analysis | 1 | 2017 | 42 | 0.040 |
Why?
| Canada | 1 | 2018 | 359 | 0.040 |
Why?
| Lipoprotein(a) | 1 | 1997 | 53 | 0.040 |
Why?
| Pelvic Bones | 1 | 2020 | 126 | 0.040 |
Why?
| Longevity | 1 | 2018 | 156 | 0.040 |
Why?
| Vitamin E | 1 | 1997 | 116 | 0.040 |
Why?
| Bicarbonates | 1 | 2017 | 47 | 0.040 |
Why?
| United Kingdom | 1 | 2018 | 260 | 0.040 |
Why?
| Receptor, ErbB-3 | 1 | 2017 | 43 | 0.040 |
Why?
| Vascular Resistance | 1 | 2018 | 372 | 0.040 |
Why?
| Galactosamine | 1 | 2016 | 4 | 0.040 |
Why?
| Biopsy, Needle | 2 | 2011 | 191 | 0.040 |
Why?
| Acetylglucosamine | 1 | 2016 | 12 | 0.040 |
Why?
| Anxiety | 1 | 2023 | 924 | 0.040 |
Why?
| Molecular Weight | 2 | 2012 | 345 | 0.040 |
Why?
| Cluster Analysis | 1 | 2018 | 497 | 0.040 |
Why?
| Random Allocation | 1 | 2018 | 377 | 0.040 |
Why?
| Anemia, Sickle Cell | 1 | 2000 | 228 | 0.030 |
Why?
| Regional Blood Flow | 1 | 2018 | 441 | 0.030 |
Why?
| Africa | 2 | 1996 | 103 | 0.030 |
Why?
| Endpoint Determination | 1 | 2017 | 67 | 0.030 |
Why?
| Disease Management | 1 | 2020 | 599 | 0.030 |
Why?
| Rotavirus Vaccines | 1 | 2016 | 48 | 0.030 |
Why?
| Protein Domains | 1 | 2017 | 223 | 0.030 |
Why?
| Antibody Affinity | 1 | 2016 | 56 | 0.030 |
Why?
| Vitreoretinopathy, Proliferative | 1 | 2016 | 12 | 0.030 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2017 | 144 | 0.030 |
Why?
| Genetic Background | 1 | 2015 | 8 | 0.030 |
Why?
| Bacteria | 1 | 2022 | 767 | 0.030 |
Why?
| Membrane Glycoproteins | 1 | 1998 | 454 | 0.030 |
Why?
| Organ Specificity | 2 | 2007 | 288 | 0.030 |
Why?
| Disease-Free Survival | 1 | 2017 | 668 | 0.030 |
Why?
| Interleukin-2 Receptor alpha Subunit | 1 | 2015 | 70 | 0.030 |
Why?
| Mice, Inbred BALB C | 2 | 2013 | 1233 | 0.030 |
Why?
| Georgia | 1 | 2015 | 61 | 0.030 |
Why?
| Florida | 1 | 2015 | 79 | 0.030 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 552 | 0.030 |
Why?
| Heterozygote | 1 | 2016 | 271 | 0.030 |
Why?
| Thyroglobulin | 2 | 2005 | 18 | 0.030 |
Why?
| HEK293 Cells | 1 | 2017 | 654 | 0.030 |
Why?
| Radioligand Assay | 2 | 2009 | 48 | 0.030 |
Why?
| DNA Primers | 1 | 1996 | 545 | 0.030 |
Why?
| Genes | 1 | 1995 | 237 | 0.030 |
Why?
| Smoking Cessation | 1 | 2019 | 398 | 0.030 |
Why?
| Washington | 1 | 2015 | 138 | 0.030 |
Why?
| Analysis of Variance | 3 | 2010 | 1366 | 0.030 |
Why?
| Hospitalization | 1 | 2004 | 1960 | 0.030 |
Why?
| Solubility | 1 | 2015 | 241 | 0.030 |
Why?
| Area Under Curve | 1 | 2015 | 305 | 0.030 |
Why?
| Insulin, Long-Acting | 2 | 2005 | 52 | 0.030 |
Why?
| Blood Pressure Determination | 1 | 2015 | 139 | 0.030 |
Why?
| Sequence Homology, Amino Acid | 1 | 2015 | 379 | 0.030 |
Why?
| Insulin Glargine | 2 | 2005 | 75 | 0.030 |
Why?
| Tunica Intima | 3 | 2000 | 80 | 0.030 |
Why?
| International Classification of Diseases | 1 | 2015 | 131 | 0.030 |
Why?
| Achievement | 1 | 2014 | 65 | 0.030 |
Why?
| Seasons | 4 | 1992 | 474 | 0.030 |
Why?
| Family Characteristics | 1 | 2015 | 171 | 0.030 |
Why?
| Epidemiologic Factors | 1 | 2013 | 8 | 0.030 |
Why?
| Plaque, Atherosclerotic | 1 | 2014 | 47 | 0.030 |
Why?
| Antigen-Antibody Reactions | 1 | 2013 | 51 | 0.030 |
Why?
| Retrospective Studies | 3 | 2014 | 13708 | 0.030 |
Why?
| Complement C1 Inactivator Proteins | 1 | 2012 | 6 | 0.030 |
Why?
| Aging | 3 | 2000 | 1706 | 0.030 |
Why?
| Complement C1 Inhibitor Protein | 1 | 2012 | 8 | 0.030 |
Why?
| Base Sequence | 2 | 2011 | 2207 | 0.030 |
Why?
| Niacinamide | 1 | 1993 | 71 | 0.030 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 1998 | 717 | 0.030 |
Why?
| Interleukin-10 | 1 | 2015 | 311 | 0.030 |
Why?
| Albumins | 1 | 2013 | 106 | 0.030 |
Why?
| California | 2 | 2004 | 385 | 0.030 |
Why?
| S100 Calcium Binding Protein beta Subunit | 1 | 2012 | 12 | 0.030 |
Why?
| S100 Proteins | 1 | 2012 | 37 | 0.030 |
Why?
| Vaccines, Inactivated | 1 | 2012 | 69 | 0.030 |
Why?
| Biometry | 1 | 1993 | 68 | 0.030 |
Why?
| Nitrates | 1 | 1992 | 79 | 0.030 |
Why?
| Comorbidity | 1 | 2017 | 1635 | 0.030 |
Why?
| Phylogeny | 2 | 2006 | 823 | 0.030 |
Why?
| Nerve Growth Factors | 1 | 2012 | 73 | 0.030 |
Why?
| Luciferases | 1 | 2012 | 154 | 0.030 |
Why?
| Residence Characteristics | 1 | 2014 | 317 | 0.030 |
Why?
| Water Supply | 1 | 1992 | 74 | 0.030 |
Why?
| Immunoprecipitation | 1 | 2012 | 170 | 0.030 |
Why?
| Genome | 1 | 2014 | 290 | 0.030 |
Why?
| Diagnostic Techniques, Endocrine | 1 | 2011 | 14 | 0.020 |
Why?
| Potassium Channels | 1 | 2012 | 138 | 0.020 |
Why?
| 25-Hydroxyvitamin D 2 | 1 | 2011 | 7 | 0.020 |
Why?
| Observation | 1 | 2011 | 57 | 0.020 |
Why?
| Adenosine Triphosphatases | 1 | 2012 | 162 | 0.020 |
Why?
| Abdominal Fat | 1 | 2012 | 48 | 0.020 |
Why?
| Ubiquitins | 1 | 2011 | 34 | 0.020 |
Why?
| Diagnosis, Differential | 2 | 2011 | 1431 | 0.020 |
Why?
| Insulinoma | 1 | 2011 | 31 | 0.020 |
Why?
| Societies, Medical | 1 | 2015 | 754 | 0.020 |
Why?
| Iodine Radioisotopes | 1 | 2011 | 133 | 0.020 |
Why?
| Brain | 1 | 2023 | 2639 | 0.020 |
Why?
| Dietary Fats, Unsaturated | 1 | 2011 | 23 | 0.020 |
Why?
| Causality | 1 | 1991 | 117 | 0.020 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 340 | 0.020 |
Why?
| Leptin | 1 | 2012 | 233 | 0.020 |
Why?
| Peptide Fragments | 2 | 2007 | 713 | 0.020 |
Why?
| Observer Variation | 1 | 2011 | 330 | 0.020 |
Why?
| Endothelium, Vascular | 2 | 2008 | 919 | 0.020 |
Why?
| Aged, 80 and over | 2 | 2018 | 6936 | 0.020 |
Why?
| DNA Replication | 1 | 2011 | 218 | 0.020 |
Why?
| Radioimmunoprecipitation Assay | 1 | 2009 | 7 | 0.020 |
Why?
| Staphylococcal Protein A | 1 | 2009 | 9 | 0.020 |
Why?
| Microchemistry | 1 | 2009 | 15 | 0.020 |
Why?
| Biostatistics | 1 | 2009 | 18 | 0.020 |
Why?
| Cholera Toxin | 1 | 2009 | 30 | 0.020 |
Why?
| Graves Disease | 1 | 2009 | 32 | 0.020 |
Why?
| Fetal Weight | 1 | 2009 | 52 | 0.020 |
Why?
| Intra-Abdominal Fat | 1 | 2010 | 102 | 0.020 |
Why?
| Vaccination | 1 | 2017 | 1241 | 0.020 |
Why?
| Calibration | 1 | 2009 | 142 | 0.020 |
Why?
| Inflammation Mediators | 1 | 2012 | 515 | 0.020 |
Why?
| DNA Mutational Analysis | 1 | 2010 | 394 | 0.020 |
Why?
| Pancreatic Polypeptide | 1 | 1989 | 4 | 0.020 |
Why?
| Microsatellite Repeats | 1 | 2009 | 144 | 0.020 |
Why?
| Survival Rate | 2 | 2006 | 1799 | 0.020 |
Why?
| Intestinal Absorption | 1 | 2009 | 104 | 0.020 |
Why?
| Chromosomes, Human, Pair 5 | 1 | 2008 | 27 | 0.020 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 2008 | 52 | 0.020 |
Why?
| Interferon-Induced Helicase, IFIH1 | 1 | 2008 | 14 | 0.020 |
Why?
| Chi-Square Distribution | 1 | 2010 | 558 | 0.020 |
Why?
| Tunica Media | 2 | 2000 | 38 | 0.020 |
Why?
| Outpatients | 1 | 1992 | 347 | 0.020 |
Why?
| Protein Precursors | 1 | 2009 | 125 | 0.020 |
Why?
| Glucagon | 1 | 1989 | 98 | 0.020 |
Why?
| Personality Inventory | 1 | 2009 | 145 | 0.020 |
Why?
| Radiography | 1 | 2011 | 893 | 0.020 |
Why?
| Telecommunications | 1 | 1988 | 19 | 0.020 |
Why?
| Pregnancy in Diabetics | 1 | 2009 | 88 | 0.020 |
Why?
| Genetic Carrier Screening | 1 | 2008 | 25 | 0.020 |
Why?
| Nutrition Therapy | 1 | 2008 | 34 | 0.020 |
Why?
| Interferon-alpha | 1 | 2009 | 193 | 0.020 |
Why?
| Pacific Islands | 1 | 1988 | 2 | 0.020 |
Why?
| Solanum tuberosum | 1 | 2008 | 9 | 0.020 |
Why?
| Americas | 1 | 1988 | 23 | 0.020 |
Why?
| Diabetic Neuropathies | 1 | 2009 | 79 | 0.020 |
Why?
| Probability | 1 | 1989 | 318 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2000 | 1008 | 0.020 |
Why?
| Asia | 1 | 1988 | 57 | 0.020 |
Why?
| Survival | 1 | 2007 | 40 | 0.020 |
Why?
| Bottle Feeding | 1 | 2007 | 22 | 0.020 |
Why?
| Carotenoids | 1 | 2007 | 36 | 0.020 |
Why?
| Vegetables | 1 | 2008 | 136 | 0.020 |
Why?
| Antibodies, Monoclonal | 1 | 2013 | 1300 | 0.020 |
Why?
| Metabolic Networks and Pathways | 1 | 2008 | 180 | 0.020 |
Why?
| Chromosomes, Human, Pair 6 | 1 | 2006 | 49 | 0.020 |
Why?
| DNA-Directed RNA Polymerases | 1 | 2006 | 53 | 0.020 |
Why?
| 5' Untranslated Regions | 1 | 2006 | 52 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2011 | 1743 | 0.020 |
Why?
| Molecular Epidemiology | 1 | 2006 | 74 | 0.020 |
Why?
| Protein Array Analysis | 1 | 2006 | 63 | 0.020 |
Why?
| Serotyping | 1 | 2005 | 32 | 0.020 |
Why?
| Self Care | 1 | 2009 | 370 | 0.020 |
Why?
| Sequence Alignment | 1 | 2006 | 338 | 0.020 |
Why?
| RNA, Messenger | 1 | 2013 | 2753 | 0.020 |
Why?
| Treatment Outcome | 2 | 2004 | 9790 | 0.020 |
Why?
| Alprostadil | 1 | 2005 | 38 | 0.020 |
Why?
| Species Specificity | 1 | 2006 | 592 | 0.020 |
Why?
| Genome, Viral | 1 | 2005 | 124 | 0.020 |
Why?
| National Institutes of Health (U.S.) | 1 | 2005 | 123 | 0.020 |
Why?
| Polyethylene Glycols | 1 | 2009 | 577 | 0.010 |
Why?
| Data Interpretation, Statistical | 1 | 2006 | 344 | 0.010 |
Why?
| Puerto Rico | 1 | 2004 | 58 | 0.010 |
Why?
| Mutation | 1 | 2015 | 3520 | 0.010 |
Why?
| Dinoprostone | 1 | 2005 | 195 | 0.010 |
Why?
| False Positive Reactions | 1 | 2004 | 122 | 0.010 |
Why?
| Ultrasonography | 2 | 2000 | 757 | 0.010 |
Why?
| Regeneration | 1 | 2005 | 177 | 0.010 |
Why?
| Embryonic and Fetal Development | 1 | 2003 | 96 | 0.010 |
Why?
| Insulin Lispro | 1 | 2003 | 35 | 0.010 |
Why?
| DNA, Viral | 1 | 2005 | 360 | 0.010 |
Why?
| Single-Blind Method | 1 | 2004 | 286 | 0.010 |
Why?
| Mice, Transgenic | 1 | 2008 | 2061 | 0.010 |
Why?
| Duodenum | 1 | 2003 | 64 | 0.010 |
Why?
| Guidelines as Topic | 1 | 2005 | 277 | 0.010 |
Why?
| Health | 1 | 2003 | 80 | 0.010 |
Why?
| Income | 1 | 2003 | 183 | 0.010 |
Why?
| HLA-A Antigens | 1 | 2002 | 50 | 0.010 |
Why?
| Models, Immunological | 1 | 2002 | 97 | 0.010 |
Why?
| Mental Recall | 1 | 2003 | 187 | 0.010 |
Why?
| Circadian Rhythm | 1 | 1985 | 420 | 0.010 |
Why?
| Blotting, Southern | 1 | 2000 | 71 | 0.010 |
Why?
| Cells, Cultured | 1 | 2008 | 4159 | 0.010 |
Why?
| Carotid Artery, Internal | 1 | 2000 | 36 | 0.010 |
Why?
| Carotid Artery, Common | 1 | 2000 | 30 | 0.010 |
Why?
| DNA, Complementary | 1 | 2000 | 276 | 0.010 |
Why?
| Cholesterol, VLDL | 1 | 1999 | 4 | 0.010 |
Why?
| Acute Disease | 1 | 2002 | 1016 | 0.010 |
Why?
| Genetic Counseling | 1 | 1999 | 69 | 0.010 |
Why?
| Signal Transduction | 1 | 2012 | 4809 | 0.010 |
Why?
| Twins, Dizygotic | 1 | 1999 | 184 | 0.010 |
Why?
| Epitope Mapping | 1 | 1998 | 51 | 0.010 |
Why?
| Lymphocyte Count | 1 | 1998 | 140 | 0.010 |
Why?
| Arthritis, Rheumatoid | 1 | 2006 | 1001 | 0.010 |
Why?
| Twins, Monozygotic | 1 | 1999 | 216 | 0.010 |
Why?
| CD4 Lymphocyte Count | 1 | 1998 | 273 | 0.010 |
Why?
| Demography | 1 | 1998 | 295 | 0.010 |
Why?
| Gene Expression Regulation | 1 | 2006 | 2492 | 0.010 |
Why?
| Cholesterol, LDL | 1 | 1998 | 341 | 0.010 |
Why?
| Quantitative Trait, Heritable | 1 | 1997 | 125 | 0.010 |
Why?
| Bacterial Infections | 1 | 1998 | 238 | 0.010 |
Why?
| Mexico | 1 | 1996 | 170 | 0.010 |
Why?
| T-Lymphocyte Subsets | 1 | 1998 | 406 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 2000 | 2512 | 0.010 |
Why?
| Quality of Life | 1 | 2005 | 2580 | 0.010 |
Why?
| Mental Disorders | 1 | 2002 | 976 | 0.010 |
Why?
| Energy Metabolism | 1 | 1998 | 786 | 0.010 |
Why?
| Baltic States | 1 | 1992 | 1 | 0.010 |
Why?
| Computer Simulation | 1 | 1997 | 953 | 0.010 |
Why?
| Software | 1 | 1997 | 647 | 0.010 |
Why?
| Rats | 1 | 2000 | 5517 | 0.010 |
Why?
| Geography | 1 | 1992 | 197 | 0.010 |
Why?
| Cohort Effect | 1 | 1990 | 4 | 0.010 |
Why?
| Periodicity | 1 | 1990 | 56 | 0.010 |
Why?
| Space-Time Clustering | 1 | 1989 | 3 | 0.010 |
Why?
| Actuarial Analysis | 1 | 1989 | 24 | 0.010 |
Why?
| Coxsackievirus Infections | 1 | 1987 | 12 | 0.000 |
Why?
| Rubella | 1 | 1987 | 22 | 0.000 |
Why?
| Cause of Death | 1 | 1989 | 394 | 0.000 |
Why?
| Mortality | 1 | 1989 | 327 | 0.000 |
Why?
| Neoplasms | 1 | 1989 | 2340 | 0.000 |
Why?
|
|
Rewers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|